BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25267570)

  • 1. BAX and CDKN1A polymorphisms correlated with clinical outcomes of gastric cancer patients treated with postoperative chemotherapy.
    Wang X; Lin Y; Lan F; Yu Y; Ouyang X; Liu W; Xie F; Wang X; Huang Q
    Med Oncol; 2014 Nov; 31(11):249. PubMed ID: 25267570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
    Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
    Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNP rs1059234 in CDKN1A Gene Correlates with Prognosis in Resected Gastric Adenocarcinoma.
    Nie X; Wang X; Lin Y; Yu Y; Liu W; Xie F; Wang X; Tan J; Huang Q
    Clin Lab; 2016; 62(3):409-16. PubMed ID: 27156331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.
    Tsujitani S; Saito H; Wakatsuki T; Ikeguchi M; Shirabe K; Morita M; Kakeji Y; Yano T; Maehara Y
    Surg Today; 2012 Feb; 42(3):225-32. PubMed ID: 22143356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of CDKN1A gene and risk of retinoblastoma.
    Carvalho IN; Reis AH; Cabello PH; Vargas FR
    Carcinogenesis; 2013 Dec; 34(12):2774-7. PubMed ID: 24045412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
    Huang ZH; Hua D; Li LH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer.
    Oh SY; Kwon HC; Kim SH; Lee S; Lee JH; Hwang JA; Hong SH; Graves CA; Camphausen K; Kim HJ; Lee YS
    BMC Cancer; 2013 Feb; 13():43. PubMed ID: 23374220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy.
    Jeong SH; Han JH; Kim JH; Ahn MS; Hwang YH; Lee HW; Kang SY; Park JS; Choi JH; Lee KJ; Sheen SS; Lim HY
    Dig Dis Sci; 2011 Jan; 56(1):131-8. PubMed ID: 20503071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.
    Lu ZM; Luo TH; Nie MM; Fang GE; Ma LY; Xue XC; Wei G; Ke CW; Bi JW
    Tumour Biol; 2014 Apr; 35(4):2941-8. PubMed ID: 24318989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI.
    Seo BG; Kwon HC; Oh SY; Lee S; Kim SG; Kim SH; Han H; Kim HJ
    Oncol Rep; 2009 Jul; 22(1):127-36. PubMed ID: 19513514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX.
    Oh SY; Shin A; Kim SG; Hwang JA; Hong SH; Lee YS; Kwon HC
    Oncotarget; 2016 May; 7(21):31204-14. PubMed ID: 27144430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
    Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
    Ji M; Xu B; Jiang JT; Wu J; Li XD; Zhao WQ; Zhang HY; Zhou WJ; Wu CP
    Onkologie; 2013; 36(6):335-40. PubMed ID: 23774147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of p21 and Her-2 gene expression and mutation/polymorphism in patients with gastric adenocarcinoma.
    Ozen A; Kocak Z; Sipahi T; Oz-Puyan F; Cakina S; Saynak M; Ibis C; Karagol H
    Med Oncol; 2013 Mar; 30(1):357. PubMed ID: 23275116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer.
    Wang X; Lin Y; Lan F; Yu Y; Ouyang X; Wang X; Huang Q; Wang L; Tan J; Zheng F
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1399-411. PubMed ID: 24737346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
    Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X
    PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
    Wu X; Gu J; Wu TT; Swisher SG; Liao Z; Correa AM; Liu J; Etzel CJ; Amos CI; Huang M; Chiang SS; Milas L; Hittelman WN; Ajani JA
    J Clin Oncol; 2006 Aug; 24(23):3789-98. PubMed ID: 16785472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53, p21, and p73 gene polymorphisms in gastric carcinoma.
    Shirai O; Ohmiya N; Taguchi A; Nakamura M; Kawashima H; Miyahara R; Itoh A; Hirooka Y; Watanabe O; Ando T; Goto Y; Hamajima N; Goto H
    Hepatogastroenterology; 2010; 57(104):1595-601. PubMed ID: 21443127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy.
    Shitara K; Matsuo K; Ito S; Sawaki A; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Muro K
    Asian Pac J Cancer Prev; 2010; 11(2):447-52. PubMed ID: 20843132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.